SLC2A1 and nasopharyngeal carcinoma: As discussed above, Glut-1 is regarded as a tumor marker due to its significant clinical relevance in EBV-associated malignancy of NPC (Sommermann et al., 2011; Szablewski, 2013; Zhang et al., 2017; Zhou et al., 2017).